MINNEAPOLIS, Jan. 18 /PRNewswire/ -- Cardiocom LLC announced today the release of its new Commander Cellular home monitoring device for individuals with chronic high risk diseases such as congestive heart failure, diabetes, chronic obstructive pulmonary disease (COPD) and severe asthma. Commander Cellular is an enhancement to Cardiocom's FDA-registered Class II Commander home telemonitoring system, which has been in use since 2002 and has received the Disease Management Association of America's "Best Enabling Tool for Disease Management" Award.
"The immediate, preemptive and objective feedback provided by Cardiocom's telehealth system helps avoid hospital admissions and improve quality of life," said Daniel L. Cosentino, Cardiocom's President, "Commander Cellular makes this solution available to an even larger patient population with chronic diseases needing health care assistance."
Commander Cellular includes an integrated cellular modem and uses GPRS technology to transmit objective health data to Cardicom's Omnivisor(TM) disease management software system. This detailed patient data can be accessed daily by nurses who are monitoring the patient's health status. The powerful software is designed using evidence based medicine and clinical guidelines to support disease management assessment and interventions.
By transmitting real-time health data every day, the patient is connected to their medical team so that their medications or treatment plans can be changed as needed. Monitoring daily vital signs and symptoms also allows the nurse to identify opportunities to coordinate care, educate the patient on their disease, improve self-management skills and promote healthier behavior.
The interactive Commander or Commander Cellular device resides in the patient's home. The device can be set up by the patient or their caregiver in minutes without the need for a nurse visit. The patient easily connects peripheral equipment such as a weight scale, blood pressure cuff, blood glucose meter, peak flow meter or pulse oximeter, which measure biometric data. When the system is turned on a friendly voice prompts the patient to respond to health status questions and transmit vital sign data.
Commander and Commander Cellular are patented home telemonitoring devices featuring a library of health status questions, branching logic, and two-way communication. Cardiocom's advanced technology and flexible design improves patient engagement and provides clinical efficiency for the medical management team.
With the addition of Commander Cellular, Cardiocom continues to expand its line of telehealth solutions for health professionals, health plans, home health agencies, hospitals and disease management companies.
About Cardiocom LLC
Cardiocom ( http://www.cardiocom.com ) is a leader in telemonitoring and disease management solutions. Founded in 1997, Cardiocom develops, manufactures and markets its own telehealth devices for congestive heart disease, diabetes, high blood pressure, obesity, COPD, Asthma, and ESRD. GlucoCom(TM) blood glucose monitoring ( http://www.glucocom.com ) was added to the Cardiocom product line in early 2006. Cardiocom's clients include some of the most respected health plans, hospital systems, home health groups and disease management vendors in the nation. Through these established relationships, Cardiocom improves the lives of thousands of people each day.
Jodie Root, Vice President, Sales & Marketing, GlucoCom(TM) a division of Cardiocom, +1-888-243-8881 or firstname.lastname@example.org.